Business Context and Reporting Period
Company: Kewaunee Scientific Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended July 31, 2006
Business Overview: The Company manufactures laboratory furniture and technical furniture. It operates as a subcontractor or supplier to dealers and subcontractors, with demand heavily dependent on laboratory construction projects.
Key Financial Metrics
| Metric (in thousands) | Q1 2007 (Ended July 31, 2006) | Q1 2006 (Ended July 31, 2005) |
|---|---|---|
| Net Sales | $19,294 | $20,308 |
| Gross Profit | $3,128 | $3,386 |
| Gross Margin | 16.2% | 16.7% |
| Operating Earnings | $491 | $1,350 |
| Net Earnings | $133 | $763 |
| Diluted EPS | $0.05 | $0.31 |
| Operating Cash Flow | $1,406 | $278 |
| Short-term Borrowings | $8,531 | $8,216 (as of April 30, 2006) |
| Working Capital | $11,011 | $11,025 (as of April 30, 2006) |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 5% to $19.3 million, driven by lower selling prices in the domestic laboratory furniture market.
- Profitability Drop: Operating earnings fell significantly to $491,000 from $1.35 million. The prior year included a one-time gain of $884,000 from the sale of the Lockhart, Texas property, which was not present in the current period.
- Expense Management: Operating expenses decreased to $2.6 million (13.7% of sales) from $2.9 million (14.4% of sales) due to lower administrative, bad debt, and marketing expenses.
- Interest Costs: Interest expense more than doubled to $187,000 from $87,000 due to higher interest rates and increased borrowing levels.
- Cash Flow Improvement: Operating cash flow improved substantially to $1.4 million from $278,000, primarily due to a $4.1 million decrease in accounts receivable.
Guidance, Outlook, and Risks
- Outlook: Management states its ability to predict future demand is "very limited" due to its role as a subcontractor and dependence on the number of laboratory construction projects.
- Cost Pressures: Earnings are impacted by rising raw material costs (stainless steel, wood, epoxy resin). The Company's ability to pass these costs to customers without affecting sales volume is a key variable.
- Accounting Changes: The Company adopted SFAS No. 123(R) effective May 1, 2006. Share-based compensation expense for the quarter was $574,000. Expected fiscal year 2007 expense is $2,298,000.
- Liquidity: The Company increased its revolving credit facility to $10 million. Outstanding advances were $8.5 million as of July 31, 2006. Management believes current sources are sufficient for ongoing requirements.
- Risks: Forward-looking statements are subject to economic, competitive, and governmental factors. The Company faces risks related to raw material price volatility and the cyclical nature of laboratory construction.
Investor Verification Checklist
- One-Time Gains: Verify the impact of the $884,000 property sale gain in the prior year to accurately assess core operating performance trends.
- Order Backlog: Monitor the order backlog, which remained relatively flat at $36.5 million compared to $36.4 million at the end of the previous quarter, despite the sales decline.
- Debt Utilization: Review the utilization of the $10 million credit facility ($8.5 million used) and the upcoming expiration dates of the facility portions in late 2006.
- Share-Based Compensation: Assess the impact of the new SFAS 123(R) adoption on future earnings, with expected annual expense of approximately $2.3 million.
- Raw Material Costs: Track the Company's ability to offset rising costs of stainless steel and epoxy resin through price increases.